PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1534372
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1534372
Asia Pacific Veterinary Vaccines Market, By Vaccine Type (Poultry Vaccine, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccine); By Technology; By Disease; By Country, Trend Analysis, Competitive Landscape & Forecast, 2019-2030
Asia Pacific Veterinary Vaccines Market Size Booming at High Single Digit CAGR of 8.42% to Touch Value of USD 4.01 Billion by 2030
Asia Pacific Veterinary Vaccines Market is expanding rapidly due to growing awareness about animal health, rising demand for livestock products, adoption of technological advancements, and government initiatives supporting animal vaccination programs.
BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated the Asia Pacific Veterinary Vaccines Market size by value at USD 2.52 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Asia Pacific Veterinary Vaccines Market size to expand at a CAGR of 8.42% reaching a value of USD 4.01 billion in 2023. The Asia Pacific Veterinary Vaccines Market is primarily driven by the increasing prevalence of zoonotic diseases and the rising awareness about animal health and welfare. As livestock and pet populations grow, the need for effective vaccination programs becomes crucial to prevent the outbreak of infectious diseases that can devastate animal populations and impact human health through zoonotic transmission. Governments and international organizations are implementing stringent regulations and promoting vaccination programs to control and eradicate diseases such as rabies, foot-and-mouth disease, and avian influenza. This regulatory support, coupled with growing public awareness, is significantly boosting the demand for veterinary vaccines in the region.
By volume, BlueWeave estimated the Asia Pacific Veterinary Vaccines Market size at 5.6 million doses in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Asia Pacific Veterinary Vaccines Market size to expand at a CAGR of 7.89% reaching a volume of 7.2 million doses by 2030. Advancements in biotechnology and vaccine development are propelling the market forward. Innovations in vaccine technology, including the development of DNA vaccines, recombinant vaccines, and vector-based vaccines, are enhancing the efficacy and safety of veterinary vaccines. These technological advancements are supported by increased investments in research and development by both public and private sectors. Further, the expanding veterinary pharmaceuticals industry, along with improved infrastructure for animal healthcare, is facilitating better distribution and accessibility of vaccines. The synergistic effect of these factors is fostering a robust growth trajectory for the Asia Pacific Veterinary Vaccines Market.
Opportunity - Surge in Awareness via Digital Campaigns
A key growth driver in the region's veterinary vaccines market is the amplifying awareness facilitated by targeted digital campaigns. Leveraging digital platforms, stakeholders disseminate vital information regarding the importance of animal vaccination, disease prevention, and healthcare advancements. These campaigns foster engagement, education, and trust among both veterinarians and pet owners, driving demand for innovative vaccine solutions. As digital literacy and connectivity expand across Asia Pacific, the market experiences a profound boost, ensuring healthier and more resilient animal populations.
Impact of Escalating Geopolitical Tensions on Asia Pacific Veterinary Vaccines Market
Escalating geopolitical tensions in the Asia Pacific region significantly impacts the veterinary vaccines market. Trade disruptions due to conflicts, such as the US-China trade war, can lead to supply chain disruptions, increasing production costs and delaying vaccine availability. Border disputes, like those between India and China, strain cross-border trade and cooperation, hindering market growth. Additionally, political instability in regions like Hong Kong and Taiwan creates uncertainty, discouraging investment and innovation in the veterinary sector. For instance, export restrictions imposed by countries involved in tensions may limit the availability of essential raw materials and finished vaccines. Consequently, these factors collectively pose challenges to the steady growth and reliability of the Asia Pacific Veterinary Vaccines Market.
Asia Pacific Veterinary Vaccines Market
Segmental Coverage
Asia Pacific Veterinary Vaccines Market - By Vaccine Type
Based on vaccine type, Asia Pacific Veterinary Vaccines Market is divided into Poultry Vaccines, Livestock Vaccines (Bovine Vaccines, Small Ruminant Vaccines), Companion Animal Vaccines (Feline Vaccines, Canine Vaccines), and Aquaculture Vaccines segments. The livestock vaccines segment is the largest vaccine type in the Asia Pacific Veterinary Vaccines Market, driven by the high demand for bovine vaccines. The dominance is attributed to the significant livestock population and the increasing prevalence of livestock diseases, which necessitate effective vaccination programs. Bovine vaccines are particularly crucial due to the economic importance of cattle in the region, including dairy and meat production. The rising awareness among farmers about animal health and the support from government initiatives also contribute to the substantial market share of livestock vaccines in the Asia Pacific region.
Asia Pacific Veterinary Vaccines Market - By Technology
Based on technology, Asia Pacific Veterinary Vaccines Market is divided into Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Conjugate Vaccines segments. The live attenuated vaccines segment is the largest in the Asia Pacific Veterinary Vaccines Market. Live attenuated vaccines are widely preferred due to their ability to induce strong and lasting immunity with fewer doses. These vaccines mimic natural infections, prompting robust immune responses. Additionally, their cost-effectiveness and efficiency in preventing various infectious diseases in animals contribute to their dominance in the market.
Competitive Landscape
Asia Pacific Veterinary Vaccines Market is fiercely competitive. Major companies in the Market include Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco, Hester Biosciences Ltd, HIPRA, Merck & Co., Virbac, China Animal Husbandry Industry Co., Ltd, Tianjin Ringpu Bio-Technology Co., Ltd, Jinyu Biotechnology Co., Ltd, and Zoetis Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Asia Pacific Veterinary Vaccines Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Asia Pacific Veterinary Vaccines Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Asia Pacific Veterinary Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. Asia Pacific Veterinary Vaccines Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising demand for animal-derived food products
- 3.2.1.2. Growing awareness of animal health
- 3.2.1.3. Increasing prevalence of zoonotic diseases
- 3.2.1.4. Expansion of key players in emerging markets
- 3.2.2. Restraints
- 3.2.2.1. High storage cost of veterinary vaccines
- 3.2.2.2. Stringent government regulations
- 3.2.2.3. Limited skilled labor
- 3.2.2.4. High development costs
- 3.2.3. Opportunities
- 3.2.3.1. Growing companion animal population
- 3.2.3.2. Rising awareness through digital campaigns
- 3.2.3.3. Government initiatives for animal health
- 3.2.4. Challenges
- 3.2.4.1. Limited access to vaccines in rural areas
- 3.2.4.2. High prices of veterinary vaccines
- 3.2.1. Growth Drivers
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. Asia Pacific Veterinary Vaccines Market: Marketing Strategies
5. Asia Pacific Veterinary Vaccines Market Overview
- 5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Billion)
- 5.2. Market Share and Forecast
- 5.2.1. By Vaccine Type
- 5.2.1.1. Poultry Vaccine
- 5.2.1.2. Livestock Vaccines
- 5.2.1.2.1. Bovine Vaccines
- 5.2.1.3. Small Ruminant Vaccines
- 5.2.1.4. Companion Animal Vaccines
- 5.2.1.4.1. Feline Vaccines
- 5.2.1.4.2. Canine Vaccines
- 5.2.1.4.3. Others
- 5.2.1.5. Aquaculture Vaccine
- 5.2.1.6. Others
- 5.2.2. By Technology
- 5.2.2.1. Live Attenuated Vaccines
- 5.2.2.2. Inactivated Vaccines
- 5.2.2.3. Toxoid Vaccines
- 5.2.2.4. Recombinant Vaccines
- 5.2.2.5. Conjugate Vaccines
- 5.2.2.6. Others
- 5.2.3. By Disease
- 5.2.3.1. Porcine Disease
- 5.2.3.2. Poultry Disease
- 5.2.3.3. Livestock Disease
- 5.2.3.4. Companion Animal Disease
- 5.2.3.5. Others
- 5.2.4. By Country
- 5.2.4.1. China
- 5.2.4.2. India
- 5.2.4.3. Japan
- 5.2.4.4. South Korea
- 5.2.4.5. Australia & New Zealand
- 5.2.4.6. Indonesia
- 5.2.4.7. Malaysia
- 5.2.4.8. Singapore
- 5.2.4.9. Vietnam
- 5.2.4.10. Rest of APAC
- 5.2.1. By Vaccine Type
6. China Veterinary Vaccines Market
- 6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Vaccine Type
- 6.2.2. By Technology
- 6.2.3. By Disease
7. India Veterinary Vaccines Market
- 7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Vaccine Type
- 7.2.2. By Technology
- 7.2.3. By Disease
8. Japan Veterinary Vaccines Market
- 8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Vaccine Type
- 8.2.2. By Technology
- 8.2.3. By Disease
9. South Korea Veterinary Vaccines Market
- 9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Vaccine Type
- 9.2.2. By Technology
- 9.2.3. By Disease
10. Australia & New Zealand Veterinary Vaccines Market
- 10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
- 10.2. Market Share & Forecast
- 10.2.1. By Vaccine Type
- 10.2.2. By Technology
- 10.2.3. By Disease
11. Indonesia Veterinary Vaccines Market
- 11.1. Market Size & Forecast, 2019-2030
- 11.1.1. By Value (USD Billion)
- 11.2. Market Share & Forecast
- 11.2.1. By Vaccine Type
- 11.2.2. By Technology
- 11.2.3. By Disease
12. Malaysia Veterinary Vaccines Market
- 12.1. Market Size & Forecast, 2019-2030
- 12.1.1. By Value (USD Billion)
- 12.2. Market Share & Forecast
- 12.2.1. By Vaccine Type
- 12.2.2. By Technology
- 12.2.3. By Disease
13. Singapore Veterinary Vaccines Market
- 13.1. Market Size & Forecast, 2019-2030
- 13.1.1. By Value (USD Billion)
- 13.2. Market Share & Forecast
- 13.2.1. By Vaccine Type
- 13.2.2. By Technology
- 13.2.3. By Disease
14. Vietnam Veterinary Vaccines Market
- 14.1. Market Size & Forecast, 2019-2030
- 14.1.1. By Value (USD Billion)
- 14.2. Market Share & Forecast
- 14.2.1. By Vaccine Type
- 14.2.2. By Technology
- 14.2.3. By Disease
15. Rest of APAC Veterinary Vaccines Market
- 15.1. Market Size & Forecast, 2019-2030
- 15.1.1. By Value (USD Billion)
- 15.2. Market Share & Forecast
- 15.2.1. By Vaccine Type
- 15.2.2. By Technology
- 15.2.3. By Disease
16. Competitive Landscape
- 16.1. List of Key Players and Their Offerings
- 16.2. Asia Pacific Veterinary Vaccines Market Share Analysis, 2023
- 16.3. Competitive Benchmarking, By Operating Parameters
- 16.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
17. Impact of Escalating Geopolitical Tensions on Asia Pacific Veterinary Vaccines Market
18. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 18.1. Boehringer Ingelheim International GmbH
- 18.2. Ceva Sante Animale
- 18.3. Elanco
- 18.4. Hester Biosciences Ltd
- 18.5. HIPRA
- 18.6. Merck & Co.
- 18.7. Virbac
- 18.8. China Animal Husbandry Industry Co., Ltd
- 18.9. Tianjin Ringpu Bio-Technology Co., Ltd
- 18.10. Jinyu Biotechnology Co., Ltd
- 18.11. Zoetis Inc.
- 18.12. Other Prominent Players
19. Key Strategic Recommendations
20. Research Methodology
- 20.1. Qualitative Research
- 20.1.1. Primary & Secondary Research
- 20.2. Quantitative Research
- 20.3. Market Breakdown & Data Triangulation
- 20.3.1. Secondary Research
- 20.3.2. Primary Research
- 20.4. Breakdown of Primary Research Respondents, By Country
- 20.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
- Figure 1 Asia Pacific Veterinary Vaccines Segmentation
- Figure 2 Asia Pacific Veterinary Vaccines Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2023
- Figure 4 Asia Pacific Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 5 Asia Pacific Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 6 Asia Pacific Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 7 Asia Pacific Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 8 Asia Pacific Veterinary Vaccines Market Share, By Country, By Value (USD Billion), 2019-2030
- Figure 9 Asia Pacific Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 10 Asia Pacific Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 11 Asia Pacific Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 12 Asia Pacific Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 13 Asia Pacific Veterinary Vaccines Market Share, By Country, By Value (USD Billion), 2019-2030
- Figure 14 China Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 15 China Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 16 China Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 17 China Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 18 India Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 19 India Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 20 India Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 21 India Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 22 Japan Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 23 Japan Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 24 Japan Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 25 Japan Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 26 South Korea Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 27 South Korea Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 28 South Korea Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 29 South Korea Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 30 Australia & New Zealand Veterinary Vaccines Market Size, By Value ((USD Billion), 2019-2030
- Figure 31 Australia & New Zealand Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 32 Australia & New Zealand Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 33 Australia & New Zealand Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 34 Indonesia Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 35 Indonesia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 36 Indonesia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 37 Indonesia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 38 Malaysia Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 39 Malaysia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 40 Malaysia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 41 Malaysia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 42 Singapore Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 43 Singapore Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 44 Singapore Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 45 Singapore Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 46 Vietnam Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 47 Vietnam Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 48 Vietnam Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 49 Vietnam Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Figure 50 Rest of APAC Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Figure 51 Rest of APAC Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Figure 52 Rest of APAC Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Figure 53 Rest of APAC Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
List of Tables
- Table 1 Asia Pacific Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 2 Asia Pacific Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 3 Asia Pacific Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 4 Asia Pacific Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 5 Asia Pacific Veterinary Vaccines Market Share, By Country, By Value (USD Billion), 2019-2030
- Table 6 China Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 7 China Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 8 China Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 9 China Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 10 India Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 11 India Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 12 India Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 13 India Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 14 Japan Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 15 Japan Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 16 Japan Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 17 Japan Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 18 South Korea Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 19 South Korea Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 20 South Korea Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 21 South Korea Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 22 Australia & New Zealand Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 23 Australia & New Zealand Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 24 Australia & New Zealand Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 25 Australia & New Zealand Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 26 Indonesia Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 27 Indonesia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 28 Indonesia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 29 Indonesia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 30 Malaysia Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 31 Malaysia Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 32 Malaysia Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 33 Malaysia Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 34 Singapore Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 35 Singapore Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 36 Singapore Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 37 Singapore Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 38 Vietnam Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 39 Vietnam Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 40 Vietnam Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 41 Vietnam Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 42 Rest of APAC Veterinary Vaccines Market Size, By Value (USD Billion), 2019-2030
- Table 43 Rest of APAC Veterinary Vaccines Market Share, By Vaccine Type, By Value (USD Billion), 2019-2030
- Table 44 Rest of APAC Veterinary Vaccines Market Share, By Technology, By Value (USD Billion), 2019-2030
- Table 45 Rest of APAC Veterinary Vaccines Market Share, By Disease, By Value (USD Billion), 2019-2030
- Table 46 Boehringer Ingelheim International GmbH Company Overview
- Table 47 Boehringer Ingelheim International GmbH Financial Overview
- Table 48 Ceva Sante Animale Company Overview
- Table 49 Ceva Sante Animale Financial Overview
- Table 50 Elanco Company Overview
- Table 51 Elanco Financial Overview
- Table 52 Hester Biosciences Ltd Company Overview
- Table 53 Hester Biosciences Ltd Financial Overview
- Table 54 HIPRA Company Overview
- Table 55 HIPRA Financial Overview
- Table 56 Merck & Co. Company Overview
- Table 57 Merck & Co. Financial Overview
- Table 58 Virbac Company Overview
- Table 59 Virbac Financial Overview
- Table 60 China Animal Husbandry Industry Co., Ltd Company Overview
- Table 61 China Animal Husbandry Industry Co., Ltd Financial Overview
- Table 62 Tianjin Ringpu Bio-Technology Co., Ltd Company Overview
- Table 63 Tianjin Ringpu Bio-Technology Co., Ltd Financial Overview
- Table 64 Jinyu Biotechnology Co., Ltd Company Overview
- Table 65 Jinyu Biotechnology Co., Ltd Financial Overview
- Table 66 Zoetis Inc. Company Overview
- Table 67 Zoetis Inc. Financial Overview
